Literature DB >> 14750100

Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study.

Jan T Kielstein1, Ulrich Kretschmer, Thomas Ernst, Carsten Hafer, Matthias J Bahr, Hermann Haller, Danilo Fliser.   

Abstract

BACKGROUND: Extended dialysis is an increasingly used modality of renal replacement therapy that theoretically offers advantages of both intermittent and continuous therapies in the intensive care unit (ICU).
METHODS: We randomly treated 39 ventilated critically ill patients with oliguric acute renal failure with either continuous venovenous hemofiltration (CVVH; n = 19; age, 50.1 +/- 3.2 years; Acute Physiology and Chronic Health Assessment II [APACHE II] score, 32.3 +/- 1.2; 79% sepsis) and a substitution fluid rate of at least 30 mL/kg/h for 24 hours or with extended dialysis for 12 hours (n = 20; age, 50.8 +/- 3.6 years; APACHE II score, 33.6 +/- 1.0; 85% sepsis). The latter was performed using an easy-to-handle, single-pass, batch dialysis system. All hemodynamic parameters were monitored invasively by means of an indwelling arterial catheter.
RESULTS: Average mean arterial blood pressure, heart rate, cardiac output, systemic vascular resistance, and catecholamine dose were not significantly different in both therapies. Urea reduction rate was similar with extended dialysis compared with CVVH therapy (53% +/- 2% versus 52% +/- 3%; P = not significant) despite an average rate of substitution fluid with the latter of 3.2 +/- 0.1 L/h. This was corroborated by the finding of similar amounts of urea eliminated in the collected spent total hemofiltration and dialysis fluid. Correction of acidosis was accomplished faster with extended dialysis than CVVH, and the amount of heparin used was significantly lower with extended dialysis (P < 0.01).
CONCLUSION: Extended dialysis combines excellent detoxification with cardiovascular tolerability, even in severely ill patients in the ICU. The technically simple dialysis system used offers flexibility of treatment time.

Entities:  

Mesh:

Year:  2004        PMID: 14750100     DOI: 10.1053/j.ajkd.2003.10.021

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  56 in total

Review 1.  Continuous renal replacement therapy: recent advances and future research.

Authors:  John R Prowle; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

2.  Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Carola Cademartiri; Aderville Cabassi; Edoardo Picetti; Maria Barbagallo; Tiziano Gherli; Giuseppe Castellano; Santo Morabito; Umberto Maggiore
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

Review 3.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

Review 4.  Renal replacement therapy review: past, present and future.

Authors:  Geoffrey M Fleming
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 6.  Prolonged intermittent renal replacement therapy in children.

Authors:  Rajiv Sinha; Sidharth Kumar Sethi; Timothy Bunchman; Valentine Lobo; Rupesh Raina
Journal:  Pediatr Nephrol       Date:  2017-07-18       Impact factor: 3.714

Review 7.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

8.  [Acute renal failure. Extracorporeal therapy].

Authors:  J T Kielstein; D Fliser
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

Review 9.  [Extracorporeal renal replacement therapy in acute kidney injury : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-15       Impact factor: 0.840

10.  Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.

Authors:  Philipp Kümpers; Carsten Hafer; Sascha David; Hartmut Hecker; Alexander Lukasz; Danilo Fliser; Hermann Haller; Jan T Kielstein; Robert Faulhaber-Walter
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.